Cerus (CERS) Cash from Investing Activities (2010 - 2026)
Cerus (CERS) posted Cash from Investing Activities of $12.9 million for Q2 2026, up 30.49% sequentially from $9.9 million in Q1 2026, and up 1281.45% YoY from $931339.7 in Q2 2025.
Cerus (CERS) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Cerus has reported Cash from Investing Activities for 17 years, with the latest figure at $12.9 million in Q2 2026.
- Quarterly Cash from Investing Activities rose 1281.45% year-over-year to $12.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.8 million (up 496.86% YoY) and the FY2025 annual result came in at -$6.2 million, up 24.17% from the prior year.
- Cash from Investing Activities advanced to $12.9 million in Q2 2026 per CERS's latest filing, from $9.9 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $12.9 million in Q2 2026 and troughed at -$7.3 million in Q4 2024.
- A 5-year average of $1.4 million and a median of -$682000.0 in 2023 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 1851.64% in 2024, down 405.15% in 2024.
- Over 5 years, Cash from Investing Activities stood at $7.4 million in 2022, then increased by 11.28% to $8.2 million in 2023, then sank by 188.68% to -$7.3 million in 2024, then surged by 81.09% to -$1.4 million in 2025, then soared by 1033.67% to $12.9 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $12.9 million, $9.9 million, and -$1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | 12.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.87 Mn |
| Jun 30, 2026 | 12.87 Mn |
| Mar 31, 2026 | 9.86 Mn |
| Mar 31, 2026 | 9.86 Mn |
| Dec 31, 2025 | -1.38 Mn |
| Dec 31, 2025 | -1.38 Mn |
| Sep 30, 2025 | -2.51 Mn |
| Sep 30, 2025 | -2.51 Mn |
| Jun 30, 2025 | -1.09 Mn |
| Jun 30, 2025 | -1.09 Mn |
| Mar 31, 2025 | -1.19 Mn |
| Mar 31, 2025 | -1.19 Mn |
| Dec 31, 2024 | -7.29 Mn |
| Dec 31, 2024 | -7.29 Mn |
| Sep 30, 2024 | 4.82 Mn |
| Sep 30, 2024 | 4.82 Mn |
| Jun 30, 2024 | -7.11 Mn |
| Jun 30, 2024 | -7.11 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.45 Mn |